Selling and Marketing Expense in USD of CorMedix Inc. from Q2 2023 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The aggregate total amount of expenses directly related to the marketing or selling of products or services.
Summary
CorMedix Inc. quarterly/annual Selling and Marketing Expense history and growth rate from Q2 2023 to Q3 2025.
  • CorMedix Inc. Selling and Marketing Expense for the quarter ending September 30, 2025 was $11.2M, a 65.7% increase year-over-year.
  • CorMedix Inc. Selling and Marketing Expense for the twelve months ending September 30, 2025 was $30.3M.
  • CorMedix Inc. annual Selling and Marketing Expense for 2024 was $28.7M, a 58.6% increase from 2023.
Selling and Marketing Expense, Trailing 12 Months (USD)
Selling and Marketing Expense, Quarterly (USD)
Selling and Marketing Expense, YoY Quarterly Growth (%)
Selling and Marketing Expense, Annual (USD)
Selling and Marketing Expense, YoY Annual Growth (%)

CorMedix Inc. Quarterly Selling and Marketing Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $30.3M $11.2M +$4.44M +65.7% Jul 1, 2025 Sep 30, 2025 10-Q 2025-11-12
Q2 2025 $25.9M $6.38M -$1M -13.6% Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-07
Q1 2025 $26.9M $4.47M -$1.86M -29.4% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-06
Q4 2024 $28.7M $8.26M Oct 1, 2024 Dec 31, 2024 10-K 2025-03-25
Q3 2024 $6.75M +$2.69M +66.3% Jul 1, 2024 Sep 30, 2024 10-Q 2025-11-12
Q2 2024 $7.39M +$4.13M +127% Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-07
Q1 2024 $6.34M Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-06
Q3 2023 $4.06M Jul 1, 2023 Sep 30, 2023 10-Q 2024-10-30
Q2 2023 $3.26M Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14

CorMedix Inc. Annual Selling and Marketing Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $28.7M +$10.6M +58.6% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-25
2023 $18.1M Jan 1, 2023 Dec 31, 2023 10-K 2025-03-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.